Cannabis Sciences Virtual Event 2018
Judy Mikovits, PhD – Founder/Consultant at M.A.R.C. INC and Director of Cancer Biology at EpiGenX Pharmaceuticals
Dr. Judy A. Mikovits earned a BA in Chemistry with a specialization in biology from the University of Virginia in 1980 and a PhD in biochemistry and molecular biology from George Washington University in 1992. Upon graduation from UVA, she went directly to the National Cancer Institute in Frederick Maryland where she developed purification methods for Interferon alpha. It was this Interferon which was used in the first immune therapy treatment for hairy cell leukemia in 1986. In 1986-7, prior to enrolling in graduate school. she went to Upjohn Pharmaceuticals in Kalamazoo Michigan to develop production methods to insure biological materials manufactured using human blood products were free of contamination from HIV-1. Her PhD thesis defense entitled “Negative Regulation of HIV Expression in Monocytes” changed the paradigm for therapeutic treatment of HIV. For this work, she was awarded the graduate student of the year in 1991. In her thirty-five-year quest to understand and develop therapies for chronic diseases, she has co-authored seminal papers culminating at least a decade of research in each of four fields: immunology, natural products chemistry, epigenetics, and HIV/AIDs drug development. In 2006, Dr. Mikovits became attracted to the plight of families with neuroimmune diseases including ME/CFS and Autism and was primarily responsible for demonstrating the relationship between environmentally acquired immune dysfunction, chronic inflammation and these diseases. Her pioneering work during a twenty year career at the National Cancer Institute includes the discovery of the modulation of DNA Methylation machinery by human retro viral infection and the development of the concept of inflammatory cytokines and chemokine signatures of infection and disease, which was first published in 1999, when Dr. Mikovits directed the Laboratory of Antiviral Drug Mechanisms in developing therapeutics and diagnostics for HIV/AIDS and AIDS associated malignancies.
Cannabis as Immunonotherapy for 21st Century Acquired Immune Deficiencies
It has only been in the last 20 years that we, the scientific/medical community, have appreciated the role of the endogenous Cannabinoid system (ECS) in maintaining a healthy immune system and brain. More recently, we recognized that the ECS is critical for stem cell development and homeostasis. The phytocannabinoid, THC is a modulator of Hematopoietic Stem Cells (HSC). It acts in part via stimulation of TGF beta production. The modulation of TGF beta, HSC and the NFkB by other natural product immunotherapy via some of the same pathways as THC suggest opportunities for synergy and decreasing psychoactive effects.
Combinations of phytocannabinoiss can be used as stem cell and immune therapy in combination with other natural products and chemotherapy as curative treatment strategies for cancer, AIDS, Autoimmune disease and chronic inflammatory diseases. Moreover, Evidence is accumulating that THC is actually reduces opioid addiction by modulating endogenous opioids. Endogenous opioids are peptides derived from food which can also modulate immune cells including hematopoietc stem cells and be valuable therapeutics against HIV/AIDS and Cancer as our collaborator, Candace Pert demonstrated in the 1980s when she/we developed peptide T as an AIDS and cancer therapeutic (book Molecules of Emotion). Endocannabinoids, phyto-cannabinoids, and opioids modulate the immune system, hematopoietic and mesenchymal stem cells, it may also modulate the opioid pathways to reduce addiction.
Earn PACE/CME Credits:
1. Make sure you’re a registered member of LabRoots (https://www.labroots.com/virtual-event/cannabis-sciences-2018)
2. Watch the webinar on YouTube above or on the LabRoots Website (https://www.labroots.com/virtual-event/cannabis-sciences-2018)
3. Click Here to get your PACE (Expiration date – March 29, 2020 12:00 PM)– http://www.labroots.com/credit/pace-credits/2816/third-party
LabRoots on Social: